Kymera Therapeutics Inc. (KYMR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Kymera Therapeutics Inc.

    NASDAQ: KYMR · Real-Time Price · USD
    43.44
    -0.07 (-0.16%)
    At close: Sep 08, 2025, 11:07 AM

    Kymera Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -13.49 -10.11 -8.87 -31.09
    PEG Ratio
    		 -0.74 0.95 -0.23 -0.29
    PS Ratio
    		 64.14 18.91 28.75 41.83
    PB Ratio
    		 3.61 3.76 2.75 6.63
    P/FCF Ratio
    		 -14.56 -10.82 -8.63 -23.34
    P/OCF Ratio
    		 -15.52 -14.45 -8.79 -23.63
    OCF/S Ratio
    		 -4.13 -1.31 -3.27 -1.77
    Debt / Equity Ratio
    		 0.11 0.21 0.04 0.04
    Quick Ratio
    		 7.53 4.73 9.04 5.71
    Current Ratio
    		 7.53 4.73 8.84 5.62
    Asset Turnover
    		 0.05 0.14 0.08 0.12
    Interest Coverage
    		 -1.05K -844.54 -916.23 -574.46
    Return on Equity
    		 -0.27 -0.37 -0.31 -0.21
    Return on Assets
    		 -0.23 -0.26 -0.25 -0.16
    Return on Invested Capital
    		 -0.28 -0.33 -0.29 -0.19
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 1.00 0.94 0.97
    Net Profit Margin
    		 -4.76 -1.87 -3.24 -1.35
    Pretax Profit Margin
    		 -4.76 -1.87 -3.31 -1.38
    Operating Profit Margin
    		 -5.56 -2.11 -3.44 -1.38
    FCF Margin
    		 -4.4 -1.75 -3.33 -1.79
    EBITDA Margin
    		 -4.59 -1.82 -3.24 -1.34

    Add to Watchlist